By Canadian Press

J&J vaccine can be used for people over 30 but mRNA vaccines still preferred: NACI

May 3, 2021 | 12:34 PM

OTTAWA — The National Advisory Committee on Immunization says the Johnson & Johnson vaccine should be limited to people over the age of 30 who don’t want to wait for Pfizer-BioNTech or Moderna. 

The advice is almost identical to that issued for the Oxford-AstraZeneca vaccine last month and comes as both are suspected of causing a new and very rare blood clotting syndrome.

In Canada there have been seven known cases of vaccine-induced thrombotic thrombocytopenia, or VITT, one of them fatal. 

As of April 24, 1.7 million people in Canada have been given at least one dose of the AstraZeneca vaccine.

No J&J doses have been injected in Canada thus far, but in the U.S. they have documented 17 cases of the blood-clotting disorder in about eight million doses given.

Meaningful Mementos

Remembering Someone You've Lost at Christmas

Dec 03, 2024

Seasonal Sorrow

How Do You Get Through The Holidays When You're Grieving?

Nov 01, 2024

Upcoming Events at Oliver's

Grief & Loss and Estate Planning Seminars

Oct 02, 2024

Canada’s first 300,000 doses of J&J are on hold at a Toronto-area warehouse pending investigation to ensure they are safe after discovering they were partly made at an American facility cited for safety and quality-control violations.

This report by The Canadian Press was first published May 3, 2021.

Mia Rabson, The Canadian Press